カテゴリー： QYResearch, 世界

世界のヒトサイトメガロウイルスエンベロープ糖タンパク質B市場 2019年

【英語タイトル】Global Human Cytomegalovirus Envelope Glycoprotein B Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X09338）・商品コード：DATA909X09338
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2024年版があります。お問い合わせください）
・ページ数：107
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、ヒトサイトメガロウイルスエンベロープ糖タンパク質Bの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、CSJ-148、CyMVectin、TRL-345、PPCM、サイトメガロウイルスワクチン、その他に、用途別には、感染症、腫瘍学、女性の健康、その他にセグメント区分し、ヒトサイトメガロウイルスエンベロープ糖タンパク質Bの世界市場を分析しました。


・エグゼクティブ・サマリー
・ヒトサイトメガロウイルスエンベロープ糖タンパク質Bの世界市場概要
・ヒトサイトメガロウイルスエンベロープ糖タンパク質Bの製造コスト構成分析
・ヒトサイトメガロウイルスエンベロープ糖タンパク質Bの開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・ヒトサイトメガロウイルスエンベロープ糖タンパク質Bの地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・ヒトサイトメガロウイルスエンベロープ糖タンパク質Bのセグメント分析（種類別）
（CSJ-148、CyMVectin、TRL-345、PPCM、サイトメガロウイルスワクチン、その他）
・ヒトサイトメガロウイルスエンベロープ糖タンパク質Bのセグメント分析（用途別）
（感染症、腫瘍学、女性の健康、その他）
・ヒトサイトメガロウイルスエンベロープ糖タンパク質Bの主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Astellas Pharma Inc.、Trellis Bioscience, Inc.、Vakzine Projekt Management GmbH、VBI Vaccine Inc、Vical Incorporated、）
・ヒトサイトメガロウイルスエンベロープ糖タンパク質Bの市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Human Cytomegalovirus Envelope Glycoprotein B market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Human Cytomegalovirus Envelope Glycoprotein B volume and value at global level, regional level and company level. From a global perspective, this report represents overall Human Cytomegalovirus Envelope Glycoprotein B market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Human Cytomegalovirus Envelope Glycoprotein B in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Human Cytomegalovirus Envelope Glycoprotein B manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Astellas Pharma Inc.
Trellis Bioscience, Inc.
Vakzine Projekt Management GmbH
VBI Vaccine Inc
Vical Incorporated
…

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
CSJ-148
CyMVectin
TRL-345
PPCM
Cytomegalovirus Vaccine
Others

Segment by Application
Infectious Disease
Oncology
Women’s Health
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Human Cytomegalovirus Envelope Glycoprotein B
1.1 Definition of Human Cytomegalovirus Envelope Glycoprotein B
1.2 Human Cytomegalovirus Envelope Glycoprotein B Segment by Type
1.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Production Growth Rate Comparison by Types (2014-2025)
1.2.2 CSJ-148
1.2.3 CyMVectin
1.2.4 TRL-345
1.2.5 PPCM
1.2.6 Cytomegalovirus Vaccine
1.2.7 Others
1.3 Human Cytomegalovirus Envelope Glycoprotein B Segment by Applications
1.3.1 Global Human Cytomegalovirus Envelope Glycoprotein B Consumption Comparison by Applications (2014-2025)
1.3.2 Infectious Disease
1.3.3 Oncology
1.3.4 Women’s Health
1.3.5 Others
1.4 Global Human Cytomegalovirus Envelope Glycoprotein B Overall Market
1.4.1 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue (2014-2025)
1.4.2 Global Human Cytomegalovirus Envelope Glycoprotein B Production (2014-2025)
1.4.3 North America Human Cytomegalovirus Envelope Glycoprotein B Status and Prospect (2014-2025)
1.4.4 Europe Human Cytomegalovirus Envelope Glycoprotein B Status and Prospect (2014-2025)
1.4.5 China Human Cytomegalovirus Envelope Glycoprotein B Status and Prospect (2014-2025)
1.4.6 Japan Human Cytomegalovirus Envelope Glycoprotein B Status and Prospect (2014-2025)
1.4.7 Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Status and Prospect (2014-2025)
1.4.8 India Human Cytomegalovirus Envelope Glycoprotein B Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Human Cytomegalovirus Envelope Glycoprotein B
2.3 Manufacturing Process Analysis of Human Cytomegalovirus Envelope Glycoprotein B
2.4 Industry Chain Structure of Human Cytomegalovirus Envelope Glycoprotein B

3 Development and Manufacturing Plants Analysis of Human Cytomegalovirus Envelope Glycoprotein B
3.1 Capacity and Commercial Production Date
3.2 Global Human Cytomegalovirus Envelope Glycoprotein B Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Human Cytomegalovirus Envelope Glycoprotein B
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Human Cytomegalovirus Envelope Glycoprotein B Production and Capacity Analysis
4.2 Human Cytomegalovirus Envelope Glycoprotein B Revenue Analysis
4.3 Human Cytomegalovirus Envelope Glycoprotein B Price Analysis
4.4 Market Concentration Degree

5 Human Cytomegalovirus Envelope Glycoprotein B Regional Market Analysis
5.1 Human Cytomegalovirus Envelope Glycoprotein B Production by Regions
5.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Production by Regions
5.1.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Regions
5.2 Human Cytomegalovirus Envelope Glycoprotein B Consumption by Regions
5.3 North America Human Cytomegalovirus Envelope Glycoprotein B Market Analysis
5.3.1 North America Human Cytomegalovirus Envelope Glycoprotein B Production
5.3.2 North America Human Cytomegalovirus Envelope Glycoprotein B Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Human Cytomegalovirus Envelope Glycoprotein B Import and Export
5.4 Europe Human Cytomegalovirus Envelope Glycoprotein B Market Analysis
5.4.1 Europe Human Cytomegalovirus Envelope Glycoprotein B Production
5.4.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Human Cytomegalovirus Envelope Glycoprotein B Import and Export
5.5 China Human Cytomegalovirus Envelope Glycoprotein B Market Analysis
5.5.1 China Human Cytomegalovirus Envelope Glycoprotein B Production
5.5.2 China Human Cytomegalovirus Envelope Glycoprotein B Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Human Cytomegalovirus Envelope Glycoprotein B Import and Export
5.6 Japan Human Cytomegalovirus Envelope Glycoprotein B Market Analysis
5.6.1 Japan Human Cytomegalovirus Envelope Glycoprotein B Production
5.6.2 Japan Human Cytomegalovirus Envelope Glycoprotein B Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Human Cytomegalovirus Envelope Glycoprotein B Import and Export
5.7 Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Market Analysis
5.7.1 Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Production
5.7.2 Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Import and Export
5.8 India Human Cytomegalovirus Envelope Glycoprotein B Market Analysis
5.8.1 India Human Cytomegalovirus Envelope Glycoprotein B Production
5.8.2 India Human Cytomegalovirus Envelope Glycoprotein B Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Human Cytomegalovirus Envelope Glycoprotein B Import and Export

6 Human Cytomegalovirus Envelope Glycoprotein B Segment Market Analysis (by Type)
6.1 Global Human Cytomegalovirus Envelope Glycoprotein B Production by Type
6.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type
6.3 Human Cytomegalovirus Envelope Glycoprotein B Price by Type

7 Human Cytomegalovirus Envelope Glycoprotein B Segment Market Analysis (by Application)
7.1 Global Human Cytomegalovirus Envelope Glycoprotein B Consumption by Application
7.2 Global Human Cytomegalovirus Envelope Glycoprotein B Consumption Market Share by Application (2014-2019)

8 Human Cytomegalovirus Envelope Glycoprotein B Major Manufacturers Analysis
8.1 Astellas Pharma Inc.
8.1.1 Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Production Sites and Area Served
8.1.2 Astellas Pharma Inc. Product Introduction, Application and Specification
8.1.3 Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Trellis Bioscience, Inc.
8.2.1 Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Production Sites and Area Served
8.2.2 Trellis Bioscience, Inc. Product Introduction, Application and Specification
8.2.3 Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Vakzine Projekt Management GmbH
8.3.1 Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Production Sites and Area Served
8.3.2 Vakzine Projekt Management GmbH Product Introduction, Application and Specification
8.3.3 Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 VBI Vaccine Inc
8.4.1 VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Production Sites and Area Served
8.4.2 VBI Vaccine Inc Product Introduction, Application and Specification
8.4.3 VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Vical Incorporated
8.5.1 Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Production Sites and Area Served
8.5.2 Vical Incorporated Product Introduction, Application and Specification
8.5.3 Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served

9 Development Trend of Analysis of Human Cytomegalovirus Envelope Glycoprotein B Market
9.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Trend Analysis
9.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size (Volume and Value) Forecast 2019-2025
9.2 Human Cytomegalovirus Envelope Glycoprotein B Regional Market Trend
9.2.1 North America Human Cytomegalovirus Envelope Glycoprotein B Forecast 2019-2025
9.2.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Forecast 2019-2025
9.2.3 China Human Cytomegalovirus Envelope Glycoprotein B Forecast 2019-2025
9.2.4 Japan Human Cytomegalovirus Envelope Glycoprotein B Forecast 2019-2025
9.2.5 Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Forecast 2019-2025
9.2.6 India Human Cytomegalovirus Envelope Glycoprotein B Forecast 2019-2025
9.3 Human Cytomegalovirus Envelope Glycoprotein B Market Trend (Product Type)
9.4 Human Cytomegalovirus Envelope Glycoprotein B Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Human Cytomegalovirus Envelope Glycoprotein B Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Human Cytomegalovirus Envelope Glycoprotein B
Table Global Human Cytomegalovirus Envelope Glycoprotein B Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Human Cytomegalovirus Envelope Glycoprotein B Production Market Share by Types in 2018
Figure CSJ-148 Product Picture
Figure CyMVectin Product Picture
Figure TRL-345 Product Picture
Figure PPCM Product Picture
Figure Cytomegalovirus Vaccine Product Picture
Figure Others Product Picture
Table Global Human Cytomegalovirus Envelope Glycoprotein B Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Human Cytomegalovirus Envelope Glycoprotein B Consumption Market Share by Applications in 2018
Figure Infectious Disease
Figure Oncology
Figure Women's Health
Figure Others
Figure Global Human Cytomegalovirus Envelope Glycoprotein B Revenue (Million USD) (2014-2025)
Figure Global Human Cytomegalovirus Envelope Glycoprotein B Production (K Pcs) (2014-2025)
Figure North America Human Cytomegalovirus Envelope Glycoprotein B Market Size (Million USD) (2014-2025)
Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size (Million USD) (2014-2025)
Figure China Human Cytomegalovirus Envelope Glycoprotein B Market Size (Million USD) (2014-2025)
Figure Japan Human Cytomegalovirus Envelope Glycoprotein B Market Size (Million USD) (2014-2025)
Figure Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Market Size (Million USD) (2014-2025)
Figure India Human Cytomegalovirus Envelope Glycoprotein B Market Size (Million USD) (2014-2025)
Table Human Cytomegalovirus Envelope Glycoprotein B Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Human Cytomegalovirus Envelope Glycoprotein B in 2018
Figure Manufacturing Process Analysis of Human Cytomegalovirus Envelope Glycoprotein B
Figure Industry Chain Structure of Human Cytomegalovirus Envelope Glycoprotein B
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Human Cytomegalovirus Envelope Glycoprotein B Manufacturing Plants Distribution
Table Human Cytomegalovirus Envelope Glycoprotein B Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Human Cytomegalovirus Envelope Glycoprotein B Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Human Cytomegalovirus Envelope Glycoprotein B Production (K Pcs) of Major Manufacturers (2014-2019)
Table Human Cytomegalovirus Envelope Glycoprotein B Production Market Share of Major Manufacturers (2014-2019)
Figure Human Cytomegalovirus Envelope Glycoprotein B Production Share by Manufacturers in 2018
Table Human Cytomegalovirus Envelope Glycoprotein B Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share of Major Manufacturers (2014-2019)
Figure Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Manufacturers in 2018
Table Human Cytomegalovirus Envelope Glycoprotein B Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Human Cytomegalovirus Envelope Glycoprotein B Production by Regions 2014-2019 (K Pcs)
Table Global Human Cytomegalovirus Envelope Glycoprotein B Production Market Share by Regions 2014-2019
Figure Global Human Cytomegalovirus Envelope Glycoprotein B Production Market Share by Regions in 2018
Table Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Regions 2014-2019 (Million USD)
Table Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Regions 2014-2019
Figure Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Regions in 2018
Table Global Human Cytomegalovirus Envelope Glycoprotein B Consumption by Regions 2014-2019 (K Pcs)
Table Global Human Cytomegalovirus Envelope Glycoprotein B Consumption Market Share by Regions 2014-2019
Figure North America Human Cytomegalovirus Envelope Glycoprotein B Production Growth Rate 2014-2019 (K Pcs)
Figure North America Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate 2014-2019 (Million USD)
Table North America Human Cytomegalovirus Envelope Glycoprotein B Production, Consumption Import and Export (K Pcs)
Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Human Cytomegalovirus Envelope Glycoprotein B Production, Consumption Import and Export (K Pcs)
Figure China Human Cytomegalovirus Envelope Glycoprotein B Production Growth Rate 2014-2019 (K Pcs)
Figure China Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate 2014-2019 (Million USD)
Table China Human Cytomegalovirus Envelope Glycoprotein B Production, Consumption Import and Export (K Pcs)
Figure Japan Human Cytomegalovirus Envelope Glycoprotein B Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Human Cytomegalovirus Envelope Glycoprotein B Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Production, Consumption Import and Export (K Pcs)
Figure India Human Cytomegalovirus Envelope Glycoprotein B Production Growth Rate 2014-2019 (K Pcs)
Figure India Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate 2014-2019 (Million USD)
Table India Human Cytomegalovirus Envelope Glycoprotein B Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Human Cytomegalovirus Envelope Glycoprotein B Market Share by Application (2014-2019)
Figure Global Value (Consumption) Human Cytomegalovirus Envelope Glycoprotein B Market Share by Application (2014-2019)
Table Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Production Sites and Area Served
Table Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Introduction, Application and Specification
Table Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Production Growth Rate (2014-2019)
Table Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Production Market Share (2014-2019)
Figure Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share (2014-2019)
Table Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Main Business and Markets Served
Table Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Production Sites and Area Served
Table Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Introduction, Application and Specification
Table Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Production Growth Rate (2014-2019)
Table Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Production Market Share (2014-2019)
Figure Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share (2014-2019)
Table Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Main Business and Markets Served
Table Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Production Sites and Area Served
Table Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Product Introduction, Application and Specification
Table Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Production Growth Rate (2014-2019)
Table Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Production Market Share (2014-2019)
Figure Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share (2014-2019)
Table Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Main Business and Markets Served
Table VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Production Sites and Area Served
Table VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Product Introduction, Application and Specification
Table VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Production Growth Rate (2014-2019)
Table VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Production Market Share (2014-2019)
Figure VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share (2014-2019)
Table VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Main Business and Markets Served
Table Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Production Sites and Area Served
Table Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Product Introduction, Application and Specification
Table Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Production Growth Rate (2014-2019)
Table Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Production Market Share (2014-2019)
Figure Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share (2014-2019)
Table Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Main Business and Markets Served
Figure Global Human Cytomegalovirus Envelope Glycoprotein B Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Human Cytomegalovirus Envelope Glycoprotein B Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Human Cytomegalovirus Envelope Glycoprotein B Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Human Cytomegalovirus Envelope Glycoprotein B Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Human Cytomegalovirus Envelope Glycoprotein B Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Human Cytomegalovirus Envelope Glycoprotein B Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Human Cytomegalovirus Envelope Glycoprotein B Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Human Cytomegalovirus Envelope Glycoprotein B by Type (2019-2025)
Table Global Consumption (K Pcs) of Human Cytomegalovirus Envelope Glycoprotein B by Application (2019-2025)
Table Human Cytomegalovirus Envelope Glycoprotein B Distributors List
Table Human Cytomegalovirus Envelope Glycoprotein B Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Astellas Pharma Inc.、Trellis Bioscience, Inc.、Vakzine Projekt Management GmbH、VBI Vaccine Inc、Vical Incorporated、

★調査レポート[世界のヒトサイトメガロウイルスエンベロープ糖タンパク質B市場 2019年] (コード：DATA909X09338)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のヒトサイトメガロウイルスエンベロープ糖タンパク質B市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のT細胞特異的表面糖タンパク質CD28市場 2019年
    DATA909X16233 / QYResearch / 2019年11月20日 / ※本調査レポートは、T細胞特異的表面糖タンパク質CD28の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、FPT-155、FR-104、ルリズマブペゴル、その他に、用途別には、プラーク乾癬、固形腫瘍、急性腎不全（ARF）、その他にセグメント区分し、T細胞特異的表面糖タンパク質CD28の世界市場を分析しました。 ・エグゼクティブ・サマリー ・T細胞特異的表面糖タンパク質CD28の世界市場概要 ・T細胞特異的表面糖タンパク質CD28の製造コスト構成分析 ・T細胞特異的表面糖タンパク質CD28の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・T細胞特異的表面糖タンパク質CD28の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・T細胞特異的表面糖タンパク質CD28のセグメント分析（種類別） （FPT-155、FR-104、ルリズマブペゴル、その他）...The global T Cell Specific Surface Glycoprotein CD28 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on T Cell Specific Surface Glycoprotein CD28 volume and value at global level, regional level and company level. From a global perspective, this report represents overall T Cell Specific Surface Glycoprotein CD28 market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of T Cell Specific Surface Glycoprotein CD28 in North America, Europe, China,...
  • 世界のT細胞表面糖タンパク質CD4市場 2019年
    DATA909X16234 / QYResearch / 2019年11月20日 / ※本調査レポートは、T細胞表面糖タンパク質CD4の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、酢酸フォリゲリモド、HIVワクチン2、イバリズマブ、その他に、用途別には、HIV、エイズ、GVHD、SARS、その他にセグメント区分し、T細胞表面糖タンパク質CD4の世界市場を分析しました。 ・エグゼクティブ・サマリー ・T細胞表面糖タンパク質CD4の世界市場概要 ・T細胞表面糖タンパク質CD4の製造コスト構成分析 ・T細胞表面糖タンパク質CD4の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・T細胞表面糖タンパク質CD4の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・T細胞表面糖タンパク質CD4のセグメント分析（種類別） （酢酸フォリゲリモド、HIVワクチン2、イバリズマブ、その他）...The global T Cell Surface Glycoprotein CD4 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on T Cell Surface Glycoprotein CD4 volume and value at global level, regional level and company level. From a global perspective, this report represents overall T Cell Surface Glycoprotein CD4 market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of T Cell Surface Glycoprotein CD4 in North America, Europe, China, Japan, Southeast Asia and...
  • 世界のC型肝炎ウイルスエンベロープタンパク質E2市場 2019年
    DATA909X08957 / QYResearch / 2019年11月20日 / ※本調査レポートは、C型肝炎ウイルスエンベロープタンパク質E2の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、E-20、MBL-HCV-1、CIGB-230、BTA-074、その他に、用途別には、C型肝炎、性器疣贅、その他にセグメント区分し、C型肝炎ウイルスエンベロープタンパク質E2の世界市場を分析しました。 ・エグゼクティブ・サマリー ・C型肝炎ウイルスエンベロープタンパク質E2の世界市場概要 ・C型肝炎ウイルスエンベロープタンパク質E2の製造コスト構成分析 ・C型肝炎ウイルスエンベロープタンパク質E2の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・C型肝炎ウイルスエンベロープタンパク質E2の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・C型肝炎ウイルスエンベロープタンパク質E2のセグメント分析（種類別） （E-20、MBL-HCV-1、CIGB-230、BTA-074、その他）...The global Hepatitis C Virus Envelope Protein E2 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Hepatitis C Virus Envelope Protein E2 volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hepatitis C Virus Envelope Protein E2 market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Hepatitis C Virus Envelope Protein E2 in North America, Europe, China,...
  • サイトメガロウイルス治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102890 / GlobalInfoResearch / 2019年9月23日 / 本調査レポートは、サイトメガロウイルス治療の世界市場について調べ、まとめました。種類別セグメントは、ガンシクロビル、バルガンシクロビル、フォスカルネット、シドフォビル、その他等、用途別セグメントは、病院薬局、小売薬局、オンライン薬局等に区分しました。サイトメガロウイルス治療の世界市場概観、企業動向、企業別サイトメガロウイルス治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・サイトメガロウイルス治療の市場概観 ・サイトメガロウイルス治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・サイトメガロウイルス治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・サイトメガロウイルス治療の世界市場規模 ・サイトメガロウイルス治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・サイトメガロウイルス治療のアメリカ市場規模推移 ・サイトメガロウイルス治療のカナダ市場規模推移 ・サイトメガロウイルス治療のメキシコ市場規模推移 ・サイトメガロウイルス治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Cytomegalovirus (CMV) is a genus of viruses in the order Herpesvirales, in the family Herpesviridae, in the subfamily Betaherpesvirinae. Humans and monkeys serve as natural hosts. Scope of the Report: The global Cytomegalovirus Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role...
  • サイトメガロウイルス病治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101582 / GlobalInfoResearch / 2019年9月12日 / 本調査レポートは、サイトメガロウイルス病治療の世界市場について調べ、まとめました。種類別セグメントは、ガンシクロビル、バルガンシクロビル、フォスカルネット、シドフォビル、その他等、用途別セグメントは、幹細胞移植、臓器移植、先天性CMV感染、その他等に区分しました。サイトメガロウイルス病治療の世界市場概観、企業動向、企業別サイトメガロウイルス病治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・サイトメガロウイルス病治療の市場概観 ・サイトメガロウイルス病治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・サイトメガロウイルス病治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・サイトメガロウイルス病治療の世界市場規模 ・サイトメガロウイルス病治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・サイトメガロウイルス病治療のアメリカ市場規模推移 ・サイトメガロウイルス病治療のカナダ市場規模推移 ・サイトメガロウイルス病治療のメキシコ市場規模推移 ・サイトメガロウイルス病治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Cytomegalovirus disease (CMV) is a viral infection that can affect one part of the body, such as the eyes, or it can spread throughout the body. Scope of the Report: The global Cytomegalovirus Disease Treatments market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important...
  • 世界のヒトエンドスタチン市場 2019年
    DATA909X09339 / QYResearch / 2019年11月20日 / ※本調査レポートは、ヒトエンドスタチンの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、純度：95％、その他に、用途別には、医療、科学研究、その他にセグメント区分し、ヒトエンドスタチンの世界市場を分析しました。 ・エグゼクティブ・サマリー ・ヒトエンドスタチンの世界市場概要 ・ヒトエンドスタチンの製造コスト構成分析 ・ヒトエンドスタチンの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ヒトエンドスタチンの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ヒトエンドスタチンのセグメント分析（種類別） （純度：95％、その他）...The global Human Endostatin market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Human Endostatin volume and value at global level, regional level and company level. From a global perspective, this report represents overall Human Endostatin market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Human Endostatin in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Human Endostatin manufacturing...
  • 世界の組み換えヒトエンドスタチン市場 2019年
    DATA909X14173 / QYResearch / 2019年11月20日 / ※本調査レポートは、組み換えヒトエンドスタチンの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、純度：95％、その他に、用途別には、医療、科学研究、その他にセグメント区分し、組み換えヒトエンドスタチンの世界市場を分析しました。 ・エグゼクティブ・サマリー ・組み換えヒトエンドスタチンの世界市場概要 ・組み換えヒトエンドスタチンの製造コスト構成分析 ・組み換えヒトエンドスタチンの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・組み換えヒトエンドスタチンの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・組み換えヒトエンドスタチンのセグメント分析（種類別） （純度：95％、その他）...The global Recombinant Human Endostatin market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Recombinant Human Endostatin volume and value at global level, regional level and company level. From a global perspective, this report represents overall Recombinant Human Endostatin market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Recombinant Human Endostatin in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の人乳強化剤市場 2019年
    DATA909X09344 / QYResearch / 2019年11月20日 / ※本調査レポートは、人乳強化剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、液体、粉末に、用途別には、オンラインストア、オフラインストアにセグメント区分し、人乳強化剤の世界市場を分析しました。 ・エグゼクティブ・サマリー ・人乳強化剤の世界市場概要 ・人乳強化剤の製造コスト構成分析 ・人乳強化剤の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・人乳強化剤の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・人乳強化剤のセグメント分析（種類別） （液体、粉末）...The global Human Milk Fortifier market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Human Milk Fortifier volume and value at global level, regional level and company level. From a global perspective, this report represents overall Human Milk Fortifier market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Human Milk Fortifier in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...

    • ◆H&Iグローバルリサーチのお客様（例）◆